These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 22547198)

  • 1. Search for a diagnostic/prognostic biomarker for the brain cancer glioblastoma multiforme by 2D-DIGE-MS technique.
    Banerjee HN; Mahaffey K; Riddick E; Banerjee A; Bhowmik N; Patra M
    Mol Cell Biochem; 2012 Aug; 367(1-2):59-63. PubMed ID: 22547198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the Transmembrane Glucose Regulated Protein 78 as a Biomarker for the Brain Cancer Glioblastoma Multiforme by Gene Expression and Proteomic Studies.
    Banerjee HN; Hyman G; Evans S; Manglik V; Gwebu E; Banerjee A; Vaughan D; Medley J; Krauss C; Wilkins J; Smith V; Banerji A; Rousch J
    J Membr Sci Technol; 2014 Feb; 4(1):. PubMed ID: 26207187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum proteomics of glioma: methods and applications.
    Somasundaram K; Nijaguna MB; Kumar DM
    Expert Rev Mol Diagn; 2009 Oct; 9(7):695-707. PubMed ID: 19817554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profiling signatures of ovarian cancer tumour suppression using 2D-DIGE and 2D-LC-MS/MS with tandem mass tagging.
    Sinclair J; Metodieva G; Dafou D; Gayther SA; Timms JF
    J Proteomics; 2011 Apr; 74(4):451-65. PubMed ID: 21237297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of differentially expressed proteins in human glioblastoma cell lines and tumors.
    Zhang R; Tremblay TL; McDermid A; Thibault P; Stanimirovic D
    Glia; 2003 Apr; 42(2):194-208. PubMed ID: 12655603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting miR-381-NEFL axis sensitizes glioblastoma cells to temozolomide by regulating stemness factors and multidrug resistance factors.
    Wang Z; Yang J; Xu G; Wang W; Liu C; Yang H; Yu Z; Lei Q; Xiao L; Xiong J; Zeng L; Xiang J; Ma J; Li G; Wu M
    Oncotarget; 2015 Feb; 6(5):3147-64. PubMed ID: 25605243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic analysis of gliomas.
    Whittle IR; Short DM; Deighton RF; Kerr LE; Smith C; McCulloch J
    Br J Neurosurg; 2007 Dec; 21(6):576-82. PubMed ID: 18071984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of serum proteome alterations in human glioblastoma multiforme.
    Gollapalli K; Ray S; Srivastava R; Renu D; Singh P; Dhali S; Bajpai Dikshit J; Srikanth R; Moiyadi A; Srivastava S
    Proteomics; 2012 Aug; 12(14):2378-90. PubMed ID: 22684992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Principal component analysis on LC‑MS/MS and 2DE‑MALDI‑TOF in glioblastoma cell lines reveals that mitochondria act as organelle sensors of the metabolic state in glioblastoma.
    Gómez-Caudillo L; Ortega-Lozano AJ; Martínez-Batallar ÁG; Rosas-Vargas H; Minauro-Sanmiguel F; Encarnación-Guevara S
    Oncol Rep; 2020 Aug; 44(2):661-673. PubMed ID: 32468038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential predictive plasma biomarkers for cervical cancer by 2D-DIGE proteomics and Ingenuity Pathway Analysis.
    Guo X; Hao Y; Kamilijiang M; Hasimu A; Yuan J; Wu G; Reyimu H; Kadeer N; Abudula A
    Tumour Biol; 2015 Mar; 36(3):1711-20. PubMed ID: 25427637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of clinically relevant protein targets in prostate cancer with 2D-DIGE coupled mass spectrometry and systems biology network platform.
    Ummanni R; Mundt F; Pospisil H; Venz S; Scharf C; Barett C; Fälth M; Köllermann J; Walther R; Schlomm T; Sauter G; Bokemeyer C; Sültmann H; Schuppert A; Brümmendorf TH; Balabanov S
    PLoS One; 2011 Feb; 6(2):e16833. PubMed ID: 21347291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Development of barcode and proteome profiling of glioblastoma].
    Naryzhnyĭ SN; Ronzhina NL; Maĭnskova MA; Beliakova NV; Pantina RA; Filatov MV
    Biomed Khim; 2014; 60(3):308-21. PubMed ID: 25019393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteome profile changes that are differentially regulated by lipid and protein phosphatase activities of tumor suppressor PTEN in PTEN-expressing U-87 MG human glioblastoma cells.
    Shim JH; Kim YS; Bahk YY
    Proteomics; 2006 Jan; 6(1):81-93. PubMed ID: 16294307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarker discovery: a proteomic approach for brain cancer profiling.
    Khalil AA
    Cancer Sci; 2007 Feb; 98(2):201-13. PubMed ID: 17233837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic and Mitochondrial Genomic Analyses of Pediatric Brain Tumors.
    Luna B; Bhatia S; Yoo C; Felty Q; Sandberg DI; Duchowny M; Khatib Z; Miller I; Ragheb J; Prasanna J; Roy D
    Mol Neurobiol; 2015 Dec; 52(3):1341-1363. PubMed ID: 25341474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentially expressed proteins in glioblastoma multiforme identified with a nanobody-based anti-proteome approach and confirmed by OncoFinder as possible tumor-class predictive biomarker candidates.
    Jovčevska I; Zupanec N; Urlep Ž; Vranič A; Matos B; Stokin CL; Muyldermans S; Myers MP; Buzdin AA; Petrov I; Komel R
    Oncotarget; 2017 Jul; 8(27):44141-44158. PubMed ID: 28498803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A unique four-hub protein cluster associates to glioblastoma progression.
    Simeone P; Trerotola M; Urbanella A; Lattanzio R; Ciavardelli D; Di Giuseppe F; Eleuterio E; Sulpizio M; Eusebi V; Pession A; Piantelli M; Alberti S
    PLoS One; 2014; 9(7):e103030. PubMed ID: 25050814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Plasma Membrane Glycoproteins Specific to Human Glioblastoma Multiforme Cells Using Lectin Arrays and LC-MS/MS.
    Park YE; Yeom J; Kim Y; Lee HJ; Han KC; Lee ST; Lee C; Lee JE
    Proteomics; 2018 Jan; 18(1):. PubMed ID: 29136334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of nordy on biological behaviors of malignant glioma cell line U87MG and the analysis of differential expression proteome].
    Xu JP; Liu H; Bian XW; Chen JH; Zhou XD; Wu YZ
    Zhonghua Bing Li Xue Za Zhi; 2007 Sep; 36(9):609-13. PubMed ID: 18070450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of NUSAP1 in progression and expansion of glioblastoma multiforme.
    Qian Z; Li Y; Ma J; Xue Y; Xi Y; Hong L; Dai X; Zhang Y; Ji X; Chen Y; Sheng M; Sheng Y; Yang L; Liu J; Dai X; Shi J; Xie T; Dong J
    J Neurooncol; 2018 Nov; 140(2):199-208. PubMed ID: 29995176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.